Rhodes was one of the catalysts for getting TMS therapy covered by insurance (commercial payers and Medicare) in all fifty United States. She has appeared internationally in the United Kingdom where she spoke in Wales and in England at the University of Nottingham’s Institute of Mental Health’s official TMS launch. This event was attended by patients, members of the UK National Health Service, and researchers from Nottingham, Oxford, and Cambridge Universities and provides the most recent example of increasing international acceptance of this highly successful therapy. The growing interest in Rhodes by the medical community and the public—both here in the U.S. and abroad—serves to provide a growing audience for the book while more significantly, the book helps spread the word about this highly effective therapy.

Martha currently devotes her time as a TMS Patient Advocate to patients and health care professionals who contact her from throughout the United States, and from as far away as Europe, South America, Canada, The Middle East, Australia, South Africa, and India through emails.

She is a featured contributor on the premier TMS patient community website. She is also on the Patient Advisory Council for Neuronetics Neurostar Advanced Therapy and the Hartford Healthcare/Institute of Living Patient and Family Advisory Council.